Report Categories
View AllRecent Articles
View All
Merck Co Inc MRK Phase 3 Oncology Trial Setback Triggers NearTerm Pullback LongTerm Upside Remains Intact
Applied Materials Inc AMAT Top SP 500 Semiconductor Play Poised for Sustained Outperformance Amid Industry Tailwinds
Is TC Energy TRP stock weakening further Q4 2025 Earnings Beat Estimates
51Talk COE Stock Share Repurchase Investor Concern 20260420
Microsoft Corporation MSFT Nuclear Energy Supply Chain Tailwinds Bolster LongTerm AI Infrastructure Growth Thesis
Grayscale Ethereum Staking ETF ETHE Top EthereumFocused Crypto ETFs Amid Institutional Adoption Surge and ETH Price Momentum
Gilead Sciences Inc GILD Schedules Participation at Four Leading Q2 2026 Healthcare Investor Conferences to Update Stakeholders on Pipeline and Operational Milestones
Honeywell International Inc HON Price Targets Reduced by Jefferies Barclays Post Q1 2026 Results Amid Aerospace Segment Headwinds
What MidCap MFICL is doing that changes everything On the Radar 20260506
Silicom SILC Slides 757 as Selling Pressure Mounts 20260515
Biotechnology vs Pharmaceuticals Key Differences Investors Should Understand
Iridium Communications IRDM Stock Jumps 428 Approaching 4557 20260518
Markets Raise Chances for a Fed Rate Hike Following Hot Inflation Report
Mobileye Global MBLY Q1 2026 Beat Revenue NA EPS Exceeds by Significant
FPI Selloff Intensifies Financials Bear the Brunt of 26304 Crore Outflows in Early May
Retail Investors Gain Direct Access to SpaceX IPO Through Major Brokerage Platforms
Meta Broadcom and Industry Leaders Launch 125 Million Semiconductor Research Hub at UCLA
Incyte Corp INCY Q1 2026 Earnings Strong EPS Beat Overshadowed by Modest Stock Dip
Xylem Q1 2026 Earnings EPS Slightly Above Estimates Amid Operational Strength
Immunome Inc IMNM Q1 2026 Earnings Narrower Loss Beats Estimates Stock Gains Modestly
BXP Q1 2026 Earnings Stellar EPS Surge Drives Optimism
WMB Q1 2026 Earnings Modest EPS Miss Amid Positive Market Reaction
Cohen Steers Infrastructure Fund UTF Holds Steady Near Resistance as Sector Dynamics Shift
UMB Financial Slides 162 Support Levels Tested Amid Sector Weakness
Sagimet Biosciences SGMT Inches Higher as Stock Tests Key Resistance at 748
Actinium Pharmaceuticals ATNM Modest Gain Above Support as Biotech Stock Holds Key Level